| Zacks Company Profile for Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY : OTC) |
|
|
| |
| • Company Description |
| CHUGAI PHARMACEUTICAL CO. LTD. is mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products for treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. CHUGAI PHARMACEUTICAL CO. LTD. is based in Tokyo, Japan.
Number of Employees: 7,778 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $23.41 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 166,851 shares |
| Shares Outstanding: 3,291.03 (millions) |
| Market Capitalization: $77,042.97 (millions) |
| Beta: 0.66 |
| 52 Week High: $31.26 |
| 52 Week Low: $18.39 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-10.95% |
-14.29% |
| 12 Week |
-18.94% |
-31.82% |
| Year To Date |
6.55% |
-0.21% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
Nihonbashi Mitsui Tower 15th Floor 2-1-1 Nihonbashi-Muromachi 2-chome Chuo-ku
-
Tokyo,M0 103-8324
JPN |
ph: 813-3281-6611
fax: - |
None |
http://www.chugai-pharm.co.jp |
|
|
| |
| • General Corporate Information |
Officers
Osamu Okuda - Chief Executive Officer and President
Hideo Teramoto - Chairman
Iwaaki Taniguchi - Executive Vice President and Chief Financial Offic
Christoph Franz - Director
Mariko Y Momoi - Director
|
|
Peer Information
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (GSAC)
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CASI)
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (ALCD.)
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OMNN)
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CGPI.)
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CATX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 171269103
SIC: 5122
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/24/25
|
|
Share - Related Items
Shares Outstanding: 3,291.03
Most Recent Split Date: (:1)
Beta: 0.66
Market Capitalization: $77,042.97 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 1.09% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.26 |
| Current Fiscal Year EPS Consensus Estimate: $0.88 |
Payout Ratio: 0.32 |
| Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: 0.04 |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 07/24/25 |
|
|
|
| |
